Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta‐analysis
- 16 February 2024
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 84 (7) , 1079-1091
Abstract
Tumour budding shows promise as a prognostic factor in various cancers, but its widespread application is hindered by the lack of large, validated studies and standardized criteria. This meta‐analysis aims to review and examine the prognostic role of tumour budding specifically in noncolorectal gastrointestinal and pancreatobiliary tract cancers, broadening our perspective on its clinical relevance. The literature review was conducted through PubMed, Embase, and Web of Science from inception till 20 February 2023. Pooled odds ratio (OR) and hazard ratio (HR) with 95% confidence interval (CI) were calculated to assess the relation between tumour budding and clinicopathologic features, as well as overall survival. Each study was evaluated using the Newcastle‐Ottawa Scale and both heterogeneity and publication bias were analysed. In this meta‐analysis of 57 studies across various cancer types, multivariate HR revealed worse overall survival in oesophageal squamous cell carcinoma (HR 3.34 [95% CI 2.21–5.04]), gastric adenocarcinoma (2.03 [1.38–2.99]), pancreatic ductal adenocarcinoma (2.56 [2.02–3.25]), and biliary tract adenocarcinoma (3.11 [2.46–3.93]) with high‐grade tumour budding. Additionally, high‐grade tumour budding consistently correlated with adverse clinicopathological features, including lymph node metastasis, lymphovascular invasion, and distant metastasis without any observed inverse association. High heterogeneity was noted. Our study suggests that tumour budding is a valuable prognostic marker in various cancers. Nonetheless, standardized criteria tailored to specific organ types are necessary to enhance its clinical utility.Keywords
This publication has 87 references indexed in Scilit:
- Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective studyAnnals of Gastroenterological Surgery, 2022
- Three‐dimensional analysis of extrahepatic cholangiocarcinoma and tumor buddingThe Journal of Pathology, 2020
- The prognostic impact of differentiation at the invasive front of biliary tract cancerJournal of Surgical Oncology, 2018
- Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervixThe Journal of Pathology: Clinical Research, 2018
- Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinomaThe Journal of Pathology, 2015
- Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinomaJournal of Surgical Oncology, 2014
- Tumor budding as a useful prognostic marker in T1‐stage squamous cell carcinoma of the esophagusJournal of Surgical Oncology, 2013
- Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapyCancer, 2009
- Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancerThe Journal of Pathology, 2007
- An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancerCancer, 1989